GREY:ATBPF - Post by User
Post by
SimonSaysLueson Apr 09, 2024 11:49pm
433 Views
Post# 35980494
Lol mushy Nov 3 2021
Lol mushy Nov 3 2021
If you are looking for potential items that could move the stock ... here are a few things to think about ...
1. 346 (acute) fast-track application and then a further acceptance from FDA 60 days later (assuming we get it)
2. 352 details to emerge - large unmet need in acute ??? Also any fast-track to go with that ???
3. chronic regimen update and further timelines on development
4. IBD candidate selection - and next steps
5. New drug development update - new drugs added to the mix
6. Sale of CITA
7. Further partnering with Nuance on acute - maybe Nuance doubles down - unlikely but what if the two sides can come to some agreement to add acute
End of November or early December corporate update (maybe we can still expect this) with a new presentation to cover some of the above items ... or other missed items